• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
✕
  • Home
  • News
  • Expert views
  • Green Chemistry Articles of Interest to the Pharmaceutical Industry

Green Chemistry Articles of Interest to the Pharmaceutical Industry

13 March 2022
Expert views

Bryan, M. C.; Dalton, C.; Díaz-Rodríguez, A.; Doerfler, J.; Engl, O. D.; Ferguson, P.; Molina, A. G.; Han, Z. S.; Hosford, J.; Howell, G. P.; Hutchby, M.; Li, W.; Munday, R. H.; Navarro, A.; Parmentier, M.; Pawlas, J.; Richardson, P. F.; Smith III, W. J.; Steven, A.; Takale, B. S.; Terrett, J. A.; Treitler, D. S.; Zeng, M. Org. Process Res. Dev. 2022, 26, 2, 251–262Publication Date: February 2, 2022 […]

The American Chemical Society (ACS) Green Chemistry  Institute (GCI) Pharmaceutical Roundtable (PR) was developed in 2005 to encourage the integration of green chemistry and green engineering into the pharmaceutical industry. The ACS GCI is a not-for-profit organization whose mission is to catalyze and enable the implementation of green and sustainable chemistry throughout the global chemistry enterprise. The ACS GCI PR is composed of pharmaceutical and biotechnology companies, including contract research/manufacturing organizations, generic pharmaceuticals, and related companies. For details of the current membership, see acsgcipr.org.

Bryan, M. C.; Dalton, C.; Díaz-Rodríguez, A.; Doerfler, J.; Engl, O. D.; Ferguson, P.; Molina, A. G.; Han, Z. S.; Hosford, J.; Howell, G. P.; Hutchby, M.; Li, W.; Munday, R. H.; Navarro, A.; Parmentier, M.; Pawlas, J.; Richardson, P. F.; Smith III, W. J.; Steven, A.; Takale, B. S.; Terrett, J. A.; Treitler, D. S.; Zeng, M.

Org. Process Res. Dev. 2022, 26, 2, 251–262Publication Date: February 2, 2022

https://doi.org/10.1021/acs.oprd.2c00020
Read more
Back to news

Related posts

2 April 2025

Expanding the Reach of Sustainable Solid-Phase Peptide Synthesis


Read more
20 March 2025

Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase


Read more
13 November 2024

Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand


Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2025 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers
    Language 1
    Language 2
    Language 3
    Privacy on this site

    We only use necessary cookies to help make a website usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies. By clicking 'Accept', you consent to the use of necessary cookies on our website. Read our privacy policy for further details. You will find it in the footer of every page you visit

    Cookie policy
    Piwik PROPowered by